EMAIL THIS PAGE TO A FRIEND

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists

Treatment of chorea associated with Huntington's disease: focus on tetrabenazine.


PMID 19689181

Abstract

Review Huntington's disease (HD) and the role of tetrabenazine (TBZ) in treating chorea associated with this disease. Discuss the pharmacology, side-effect profile, drug interactions, precautions, and contraindications of TBZ. Literature identified within MEDLINE and PubMED. Two manuscripts specifically regarding the management of chorea in patients with HD were identified. Additionally, studies involving the clinical use of TBZ were reviewed. The literature identified provided information regarding the efficacy, safety, and pharmacological actions of TBZ. HD is often accompanied by chorea, and the treatment with TBZ in this patient population often results in decreased chorea. Pharmacists managing patients on TBZ need to be well versed in TBZ's potential side effects, drug interactions, and unique dosing considerations.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

T2952
Tetrabenazine, ≥98% (HPLC), solid
C19H27NO3